Advertisement

Cardiologie pp 237-241 | Cite as

28 Circulatieondersteuning

  • J. R. Lahpor
Part of the Quintessens book series (QUI)

Samenvatting

In dit hoofdstuk worden de technische en klinische aspecten behandeld van de mechanische ondersteuning van een falende circulatie met behulp van uitwendige en implanteerbare ‘ventricular assist devices’ (VAD’s). De meest toegepaste VAD’s zullen worden besproken.

Literatuur

  1. Copeland JG, Arabia FA, Tsau PH. Total artificial hearts: bridge to transplantation. Cardiol Clin. 2003;21:101–13.PubMedCrossRefGoogle Scholar
  2. DeBakey ME. A miniature implantable axial flow ventricular assist device. Ann Thorac Surg. 1999;68:637–40.PubMedCrossRefGoogle Scholar
  3. DeVries WC, AndersonJL, Joyce En. Clinical use of the total artificial heart N Engl J Med. 1984;310:273–8.PubMedCrossRefGoogle Scholar
  4. El-BanayosyA, Deng M, Loisance DY. The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-center study. Eur J Cardiothorac Surg. 1999;15:835–41.PubMedCrossRefGoogle Scholar
  5. Farrar DJ, Hill JD, Pennington DG. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the Thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg. 1997;113:202–9.PubMedCrossRefGoogle Scholar
  6. Frazier OH, Wampler RK, Duncan JM. First human use of the Hemopump, a catheter-mounted ventricular assist device. Ann Thorac Surg. 1990;49:299–304.PubMedCrossRefGoogle Scholar
  7. Guyton RA, Schönberger JPAM, Gray LA Jr. Postcardiotomy shock: clinical evaluation of the Abiomed BVS 5000 biventricular support system. Ann Thorac Surg. 1993;56:346–56.PubMedCrossRefGoogle Scholar
  8. Holman WL, Park SJ, Long JW. Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant. 2004;23:1359–65.PubMedCrossRefGoogle Scholar
  9. Kantrowitz A, Tjonneland S, Freed PS. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:135–40.CrossRefGoogle Scholar
  10. Körfer R, El-Banayosy A, Arusoglu L. Single-center experience with the Thoratec ventricular assist device. J Thorac Cardiovasc Surg. 2000;119:596–600.PubMedCrossRefGoogle Scholar
  11. Lahpor JR, Jonge N de, Swieten HA van. Left ventricular assist device as bridge to transplantation in patients with end-stage heart failure. Neth Heart J. 2002;10:267–71.PubMedCentralPubMedGoogle Scholar
  12. Long JW, Abdallah G, Kfoury G. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail. 2005;11:133–8.PubMedCrossRefGoogle Scholar
  13. Nemeh HW, Smedira NG. Mechanical treatment of heart failure: the growing role of LVADs and artificial hearts. Cleve Clin J Med. 2003;70:223–33.PubMedCrossRefGoogle Scholar
  14. Noon GP, Ball JW, Short HD. Bio-Medicus centrifugal ventricular support for postcardiotomy cardiac failure: a review of 129 cases. Ann Thorac Surg. 1996;61:291–5.PubMedCrossRefGoogle Scholar
  15. Siegenthaler MP, Brehm K, Strecker T. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience. J Thorac Cardiovasc Surg. 2004;127:812–22.PubMedCrossRefGoogle Scholar

Copyright information

© Bohn Stafleu van Loghum, Houten 2008

Authors and Affiliations

  • J. R. Lahpor
    • 1
  1. 1.Universitair Medisch Centrum UtrechtUtrecht

Personalised recommendations